Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy

The two properties strengthen the Company's presence in Illinois, where it currently owns and manages three other properties.

Abbott (ABT) wins FDA approval for Volt PFA system in AFib treatment

Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 22, Abbott ...
Hosted on MSN

This dividend stock just scored an FDA win. Should you buy shares now?

Abbott Laboratories (ABT), the global healthcare titan, announced on Dec. 22 that the U.S. Food and Drug Administration (FDA) has approved its Volt™ PFA System for treating atrial fibrillation (AFib).
Seeking Alpha

Abbott Laboratories Basking In A Sharp Turn In Sentiment

Abbott Laboratories' stock has surged 25% in eight months, outperforming peers on strong medical device growth and perhaps market rotation to names with less perceived macro and geopolitical risk.